Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Noevir Holdings Co Ltd
4928Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel and aircrafts. The company also produces and sells toiletries; market research; and provides air transportation and training services. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Chuo, Japan. Address: 6-13-1 Minatojima-Nakamachi, Chuo, Japan, 650-8521
Analytics
Zielpreis von Wall Street
821 062.41 JPYKGV
21.3432Dividendenrendite
4.86 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 4928
Dividenden-Analyse 4928
Dividendenwachstum über 5 Jahre
22 %Kontinuierliches Wachstum
3 JahreAusschüttungsquote 5-Jahres-Durchschnitt
99 %Verlauf der Dividende 4928
Bewertung der Aktie 4928
Finanzen 4928
Ergebnisse | 2019 | Dynamik |